Treffer 1 - 3 von 3 für Suche 'Kalsch, Brigitte', Suchdauer: 0,40s Treffer weiter einschränken
  1. 1
    Efficacy and safety of the ghrelin-O-acyltransferase inhibitor BI 1356225 in overweight/obesity: Data from two Phase I, randomised, placebo-controlled studies

    Efficacy and safety of the ghrelin-O-acyltransferase inhibitor BI 1356225 in overweight/obesity: Data from two Phase I, randomised, placebo-controlled studies von Bianzano, Susanna, Henrich, Andrea, Herich, Lena, Kalsch, Brigitte, Sarubbi, Donald, Seitz, Friedeborg, Forst, Thomas


    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  2. 2
    A randomized phase I study of BI 1820237, a novel neuropeptide Y receptor type 2 agonist, alone or in combination with low‐dose liraglutide in otherwise healthy men with overweight or obesity

    A randomized phase I study of BI 1820237, a novel neuropeptide Y receptor type 2 agonist, alone or in combination with low‐dose liraglutide in otherwise healthy men with overweight... von Beetz, Nadine, Kalsch, Brigitte, Forst, Thomas, Schmid, Bernhard, Schultz, Armin, Hennige, Anita M.

    Veröffentlicht in Diabetes, obesity & metabolism

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  3. 3
    Efficacy and safety of propafenone sustained release in the prophylaxis of symptomatic paroxysmal atrial fibrillation (The European Rythmol/Rytmonorm Atrial Fibrillation Trial [ERAFT] Study)

    Efficacy and safety of propafenone sustained release in the prophylaxis of symptomatic paroxysmal atrial fibrillation (The European Rythmol/Rytmonorm Atrial Fibrillation Trial [ERA... von Meinertz, Thomas, Lip, Gregory Y.H, Lombardi, Fedrico, Sadowski, Zigmunt P, Kalsch, Brigitte, Camez, Anne, Hewkin, Ann, Eberle, Siegfried


    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:

Suchwerkzeuge: